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Abstract. Radiation-damaged nanodiamonds (DNDs) are potentially ideal optical contrast agents for photoacoustic
(PA) imaging in biological tissues due to their low toxicity and high optical absorbance. PA imaging contrast agents
have been limited to quantum dots and gold particles, since most existing carbon-based nanoparticles, including
fluorescent nanodiamonds, do not have sufficient optical absorption in the near-infrared (NIR) range. A new DND
by Heþ ion beam irradiation with very high NIR absorption was synthesized. These DNDs produced a 71-fold
higher PA signal on a molar basis than similarly dimensioned gold nanorods, and 7.1 fmol of DNDs injected
into rodents could be clearly imaged 3 mm below the skin surface with PA signal enhancement of 567%
using an 820-nm laser wavelength. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License.
Distribution or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1
.JBO.18.2.026018]
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1 Introduction
Photoacoustic (PA) imaging, a high-resolution noninvasive im-
aging technique, was recently proposed for biomedical applica-
tions. PA imaging uses a short, focused laser power pulses to
image tissues. Tissue components or agents that absorb the
laser energy undergo rapid microheating and generate ultrasonic
waves due to transient thermoelastic expansion. These ultrasonic
emissions are detected by a transducer and used to reconstruct a
three-dimensional (3-D) image of the tissue structure based on
optical absorption.1 PA imaging provides better spatial resolution
even in deep regions of biological tissues than pure optical im-
aging, such as optical coherence tomography and diffuse optical
tomography, because scattering of ultrasonic energy is lower than
optical energy in biological tissue. Signal-to-noise ratios of 26 dB
can be achieved as deeply as 40 mm.2,3 Since PA imaging is an
optical absorption-based technique, and also near-infrared (NIR)
laser can be tuned to the optical absorption characteristics of the
structures of interest, PA imaging has superior contrast and speci-
ficity compared to ultrasonic imaging. PA imaging is especially
well-suited to image and characterize tumor vasculature, invasion,
and angiogenesis in vivo,4–6 and PA imaging can measure cyto-
toxin-induced apoptosis in tumors in vivo.7 In clinical trials, PA
has provided excellent contrast and differentiation of breast
malignancies compared to x-ray at depths of nearly 5 cm.8
PA imaging contrast in tissues and vasculature can be greatly
enhanced with exogenous optical contrast agents, such as
NIR dyes, gold nanoparticles and carbon nanoparticles.9–11
Compared to NIR dyes, due to the well-established surface
modification with biologically relevant entities for the tumor-
targeting studies and the enhanced permeability and retention
(EPR) effect that was used to image subcutaneous tumors, nano-
materials stand out as the most significant class of materials
being explored for PA imaging applications.6,12
Gold-based nanomaterials, in particular gold nanoshells,
nanorods and nanocages, are among the most useful optical
contrast agents in PA imaging due to their size- and shape-
dependent plasmonic properties.13 The tunability of their peak
absorption in the NIR range renders them suitable for image-
guided therapy and photothermal ablation of tumors.14–16
Gold is considered relatively inert and generally nontoxic; how-
ever, gold nanoparticles ranging from 8 to 37 nm have induced
severe sickness and mortality in mice.17
In previous studies, it has been demonstrated that nanodia-
monds (NDs) are nontoxic in numerous in vitro and in vivo ani-
mal studies and in a variety of different cell types.18,19 In this
study, we have developed new radiation-damaged nanodia-
monds (DNDs) with high optical absorbance in the NIR as a
new contrast agent for PA imaging, and we compared optical
absorption and imaging contrast capabilities of DNDs with
those of AuNRs and SWNTs.
Natural and man-made nanodiamonds are neither fluorescent
nor optically absorptive in the NIR, limiting their use for bio-
medical imaging. Fluorescent nanodiamonds (FNDs) were
developed by introducing nitrogen-vacancy (N-V), Si-vacancy
(Si-V) and Ni-N complex centers by ion impaction. The vacancy
band gap can be tailored to impact high optical absorption
capacity, strong fluorescent quantum yields and resistance to
photobleaching.20 Due to their biocompatibility and high spe-
cific surface area, folate- and transferrin-coupled FNDs have
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been utilized as receptor-mediated targeting of cancer cells to
investigate the uptake mechanism.21,22 Although FNDs show
exceptional photostability under high power laser excitation
and consistent fluorescence intensity after surface functionaliza-
tion,23 reductions in size affect the relative stability of the H3
and N-V centers in type IA diamond. For example, the fluores-
cence intensity was decreased 81% when the particle size of
1 mg∕mL FNDs was decreased from 350 to 50 nm.24
Preferably, nanoparticles intended for long circulation and accu-
mulation in leaky tumors should be less than 200 nm, and par-
ticles intended for lymphatic uptake and imaging generally
should be between 10 and 80 nm.25 In addition, fluorescence
imaging has poor spatial resolution at depths beyond one trans-
port mean free path (∼1 mm), which severely limits fluores-
cence imaging’s clinical potential.
In this study, we report the optical properties of DNDs with
high NIR absorption and a diameter of 70 nm for use with PA
imaging. Moreover, we show the feasibility of DNDs as contrast
agents for PA imaging and capability of deep imaging both ex
vivo and in vivo. In addition, we demonstrate that DNDs can
serve as an excellent contrast agent in the PA imaging modality
based on excellent biological compatibility and higher optical
absorption capacity compared with AuNRs and single-wall car-
bon nanotubes (SWNT).
2 Materials and Methods
All of the chemicals were purchased from Sigma-Aldrich and
used without further purification. AuNRs were freshly prepared
by the seed-mediated growth method.26 Atomic Absorption
Spectroscopy was performed on a VarianSpectrAA GTA-110
with a graphite furnace to determine the concentration of Au.
Transmission Electron Microscopy (FEI Tecnai F20 XT Field
Emission TEM) was used to determine mean dimensions of
25 × 82 nm and 18 × 90 nm for 760 and 840 nm AuNRs,
respectively. SWNT were purchased from Unidym (Sunnyvale,
California) with dimensions of 1.2 × 600 nm and a molecular
weight of ca. 1.04 × 106 g∕mol.
2.1 DND Synthesis
Natural diamond powders (Microdiamant, Lengwil,
Switzerland) were radiation-damaged with 40-keV Heþ ions
generated from a home-built ion beam apparatus as previously
described.27 To perform the ion irradiation, diamond powders
were first deposited on a long copper tape as a thin film and
then exposed to ion bombardment (∼3 × 1015 Heþ∕cm2). After
being cleaned in concentrated H2SO4-HNO3 (3∶1, v∕v) at
100°C in a microwave reactor for 3 h, the freshly prepared
DNDs were extensively rinsed in deionized (DI) water
and stored at room temperature before use. ZetaPALS
(Brookhaven Instrument Corporation, Holtsville, New York)
was used to determine mean dimensions of the DNDs as
68.7 nm (variance of 0.057) (Fig. 1). TEM image analysis
with ImageJ measured an average DND diameter of 58.3 nm
(standard deviation of 6.5 nm) (data not shown). X-ray diffrac-
tion patterns of DNDs were collected using monochromated
CuKα radiation (λ ¼ 1.54178 Å, 45 kV) on a Bruker
Proteum Diffraction System.
2.2 Peak Wavelength and In Vitro Sensitivity
The peak optical characteristics of the DNDs were measured
using the 10-MHz transducer (37.5-mm focal length; 65.81%
−6-dB fractional bandwidth, V315, Olympus NDT, Waltham,
Massachusetts). DNDs suspended in DI water were injected
into clear Tygon tubing (1 mm ID, 1.78 mm OD) and imaged
by PA imaging at different laser wavelengths. Both the trans-
ducer and the tubing containing the DNDs suspension were
immersed in the water. Measurements were repeated five
times and were referenced to DI water. The laser fluences
used in peak wavelength and sensitivity experiments were 18
and 16 mJ∕cm2, respectively. For peak wavelength determina-
tions, signal intensities from DND suspensions were acquired at
each wavelength using the same tubing. For the in vitro sensi-
tivity experiment, DND suspensions at different concentrations
were injected into tubing for signal detection. The peak absorp-
tion wavelength (820 nm) was used to determine the sensitivity
of detection. The optical absorbance of DNDs was measured in
a Molecular Devices SpectraMax (Sunnyvale, California).
Integrating sphere measurements were taken with a Hitachi
U-3900 spectrometer with a ϕ60 integrating sphere.
2.3 Ex Vivo Imaging in Raw Chicken Breast
The DNDs were suspended in water (41.67 μg∕mL, 20 μL) and
injected into a raw chicken breast at differing depths. The
25-MHz transducer (15-mm focal length; 61% −6-dB fractional
bandwidth, I3-2506-R, Olympus NDT, Waltham,
Massachusetts) was used to image the breast immediately
after injection. Following imaging, the breast was cut open
and the DNDs were photographed.
2.4 In Vivo Imaging in Mice
Balb/c mice were anesthetized using isoflurane and placed on a
thermostatic pad for PA imaging, in accordance with protocols
approved by the University of Kansas IACUC. A 30-μL suspen-
sion of DNDs (90.3 μg∕mL, 0.238 nM) in 10% phosphate buf-
fered saline (PBS) was injected subcutaneously into the lower
back of a mouse. The 5-MHz transducer (35-mm focal length;
70% −6-dB fractional bandwidth, SU-108-013, Sonic
Concepts) was used to image the injection area. Afterwards,
the imaging depth was measured by injecting DNDs into the
Fig. 1 TEM image of DNDs. Insert shows particle size distribution of
DNDs with average size of ∼68.7 0.057 nm.
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ventral side of the thigh of the mouse, and PA images were taken
from the dorsal side. The laser fluence used in both ex vivo and
in vivo experiments was 18 mJ∕cm2.
3 Results and Discussion
DNDs were prepared by ion irradiation of natural (type IA) dia-
mond powders at a high dosage (∼3 × 1015 Heþ∕cm2). This
high-dose irradiation created a high concentration (up to
3000 ppm) of vacancies in the diamond crystal lattice. These
vacancies, predominantly present in neutral form, are termed
as GR1 defect centers. After irradiation to create the vacancies
and subsequent strong acid treatments, characteristic diffraction
patterns of diamond (111), (220), and (311) peaks were clearly
observed in DNDs (data not shown), which indicated that there
was no significant damage to the crystal lattice of natural
diamond.
Previously, we reported the PA imaging of type Ib diamond
nanocrystals conjugated with gold nanoparticles.28 FNDs have
negatively charged ðN − VÞ− centers, giving a red fluorescence
emission at 600 to 800 nm. However, these FNDs do not provide
high PA signal intensity in the absence of the gold conjugate.
DNDs have GR1 neutral centers, which have a fluorescence
life time (τ) of 1 ns at room temperature, whereas the intrinsic
lifetime (τ0) is on the order of 100 nm.
29,30 Thus, the fluores-
cence quantum yield of DNDs should be ca. ∼1% at room tem-
perature, according to the equation of ΦF ¼ τ∕τ0. However, the
GR1 defects have a zero-phonon line at 741 nm with an absorp-
tion tail extending to ∼800 nm.31 Thus, 99% of the energy
absorbed by the DND is released by nonradiative processes,
e.g., vibration heating, which may contribute to the PA signal
intensity. With the feasibility of producing a high concentration
of GR1 centers in the particles, DNDs are well suited for PA
imaging applications without the addition of optically active
gold conjugates.
The experimental setup for PA imaging of DNDs is shown in
Fig. 2. The deep reflection-mode PA imaging system is capable
of sub 0.2-mm resolution at depths of 19 mm and a penetration
depth of up to 38 mm.32 For this study, we used our previously
described PA apparatus,3 including a 532-nm Q-switched Nd:
YAG laser (Surelite III, Continuum, Santa Clara, California)
that pumps an optical parametric oscillator laser (Surelite
OPO PLUS, Continuum, Santa Clara, California) with 6-ns
pulses at 10 Hz. The output is conveyed through an optical
condenser to generate a ring-shaped illumination, which is
depth focused in tissues using a condenser lenses and a focused
transducer. The beam diameter was 7 mm at the tissue surface,
and the laser intensity was restricted to 20 mJ∕cm2 in accor-
dance with the laser safety limits recommended by the
American National Standards Institute. The generated PA signal
recorded by the transducer was amplified through a preamplifier
(5072PR, Olympus-NDT, Waltham, Massachusetts) and then
collected by a PC through an A/D Scope Card (CS21G8-
256MS, Gage) with a 125-MHz sampling rate; these data
were analyzed and used to create PA images.
The optical characteristics of the DNDs were measured by
PA and absorbance spectroscopy with an integrating sphere
(Fig. 3). The optical absorbance did not have a clear maximum
due to high optical scattering. The integrating sphere measure-
ment indicated decreasing absorbance from 590 to 780 nm
[Fig. 3(a)], similar to the PA signal trend from 700 to 780 nm
[Fig. 3(b)]. The PA signal and integrating sphere absorbance
were in agreement up to about 950 nm, with the exception
of the PA maximum at 820 nm. The integrating sphere absorb-
ance increased beyond 950 nm whereas PA signal intensity
decreased. This may be due in part to our laser system’s reduced
intensity at wavelengths above 900 nm and the resulting reduced
signal-to-noise ratio.
The PA signal amplitude peaked at 700 nm with a second
peak at 820 nm. Wavelengths between 700 and 900 nm are
ideal for NIR imaging of biological tissues, since the absorption
contributions of hemoglobin, water, and Mie scattering are weak
compared to wavelengths below 700 nm. We used 820 nm for
subsequent PA imaging of the DNDs. Figure 4 indicates a non-
linear increase in peak-to-peak PA signal amplitude with
increasing DNDs concentration. Moreover, there was a signifi-
cant difference in the PA signal intensity of DI water (0.0035
0.0006 V ) and DND suspensions above the concentration
of 0.8 μg∕mL (0.0219 0.0004 V). At higher DND
Fig. 2 Schematic of PA imaging system.
Fig. 3 Optical characteristics of DNDs suspended in DI water as a func-
tion of wavelength. (a) Absorption spectrum measured with an integrat-
ing sphere, and (b) photoacoustic (PA) spectrum.
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concentrations, the penetration depth of light into the highly
scattering medium decreases, and thus the laser intensity at
the focus area decreases. Therefore, the PA signal amplitude
gradually levels off at higher concentrations of DNDs.
The DNDs were then imaged in raw chicken breast as an ex
vivo model. The maximum-amplitude-projected (MAP) image
of the chicken breast tissue after the injection of DNDs at a
depth of 3 mm [Fig. 5(a)] distinctly shows the regions with
and without DNDs presented obviously. The DND injected
area increased contrast by 446% compared to the background
chicken breast tissue, with a relative standard deviation
(RSD) of 33%. A B-scan showed that DNDs can be imaged
at a depth of ∼9.5 mm with 79% signal enhancement and
47% RSD [Fig. 5(c)].
The DNDs were next imaged after subcutaneous injection
into the lower back of a mouse. The injection site and the
path along which the needle was withdrawn are clearly visible
against the tissue background [Fig. 6(a)]. The DNDs enhanced
the PA signal contrast 919% with a 34% RSD. In a second injec-
tion at ca. 3 mm into the hip of the mouse [Fig. 6(b)], the DNDs
enhanced the contrast 567% compared to surrounding tissues
with a 19% RSD.
To further understand the signal enhancement of DNDs, we
collected and compared the PA signals of DNDs imaged at
820 nm wavelength to AuNRs having longitudinal absorption
wavelengths of 760 nm and 840 nm, and to SWNTs having
a maximum absorption wavelength of 970 nm. The concentra-
tions of different nanoparticles were adjusted to achieve similar
PA intensities in order to limit nonlinearity effects in the com-
parison. The PA amplitudes of DNDs, AuNRs and SWNTs were
calculated on an atom and particle basis using the following
equation:
Vn ¼ Amp∕ðCatom orCparticleÞ; (1)
where Vn is PA amplitude in volt per number concentration,
Amp is PA amplitude, Catom is the number concentration of
gold or carbon atoms, and Cparticle is the number concentration
of DNDs, AuNRs or SWNTs.
The PA amplitude of DNDs was 1.76 and 1.58 times stronger
than AuNRs of 760 and 840 nm, respectively, on an atom basis.
On a weight basis, the DNDs produced a signal and 29- and 26-
fold greater than AuNRs. On a nanoparticle molar basis, the
DNDs produced a signal 71 and 64 times greater than the
two AuNRs samples, despite similar longitudinal dimensions.
When compared with SWNTs, DNDs exhibited 1.67 and
Fig. 4 Peak-to-peak photoacoustic signals from DNDs in water.
Fig. 5 Photoacoustic images taken after injecting DNDs into chicken breast tissue. (a) MAP image; (b) corresponding photograph of DNDs in chicken
breast tissue (dashed circle); (c) B-scan image.
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621-fold greater PA amplitude based on atom and particle molar
concentrations, respectively, as shown in Table 1.
The improved PA contrast with DNDs compared to AuNRs
may be due in part to both the optical absorbance and the high
thermal conductivity of DNDs. Diamond has the highest thermal
conductivity of all known natural materials. For example,
the thermal conductivity for single crystal diamond is
1200 W∕m · K, which is over three times greater than that of
copper at 20°C.33 The interfacial thermal conductance is the
inverse of the interfacial thermal resistance, which is a measure
of an interface’s resistance to thermal flow. Therefore, lower
interfacial thermal resistance or higher interfacial conductance
of nanoparticles leads to faster heat transfer from the particles
to the ambient medium, which is DI water or biological fluids in
this study, and this may result in stronger PA signals. However,
this explanation does not fully explain the improved signal com-
pared to SWNTs, which have larger on-axis thermal conductiv-
ities, in excess of 30;000 W∕m · K, despite a low off-axis
conductivity of ca. 1.52 W∕m · K.34 Also, the effects of thermal
diffusion are generally thought to be negligible over the short
excitement pulse length used for PA imaging.35 Hydrogen bond-
ing also could play a role in the improved PA amplitude of
DNDs. Chen et al. found that silica-coated AuNRs produced
three-fold higher PA signals than uncoated AuNRs, because
the hydroxyl groups of the silica surface were able to form
hydrogen bonds with water and lowered the interfacial thermal
resistance.36 The surfaces of SWNTs and unmodified nanodia-
monds are very hydrophobic, and the hydrogen bonding inter-
actions between the carbon atoms and the water are very weak.37
However, the surface of our DNDs was prepared to have car-
boxyl groups by strong oxidative acid treatment;38 carboxylic
acids are strong hydrogen bond acceptors in water. As a
result, the interfacial thermal conductance of DNDs may
be higher due to the very hydrophilic surface exposed to the
aqueous milieu.
Fig. 6 Photoacoustic images taken after injecting DNDs subcutane-
ously at (a) the back (MAP image) and (b) the ventral side of the
thigh of mouse (B-scan image).
Table 1 Comparison of PA signals between DNDs, AuNRs and SWNT.
Particles Amp (mV)a Cm (mg∕mL)b
Atom molar
concentration (M) Catom (atoms∕L)c Vn (mV∕ðatoms∕LÞ)d
DNDs 277.9 11.3 0.04 3.33 × 10−3 2.00 × 1021 139.0 × 10−21
SWNT (970 nm) 166.9 5.5 0.04 3.33 × 10−3 2.00 × 1021 83.4 × 10−21
AuNRs (760 nm) 268.3 3.6 1.11 5.63 × 10−3 3.39 × 1021 79.1 × 10−21
AuNRs (840 nm) 281.0 1.7 1.05 5.33 × 10−3 3.21 × 1021 87.5 × 10−21
Particles Amp (mV) Cm (mg∕mL)
Particle molar
concentration (M) Cparticle (nps∕L)e Vn (mV∕ðnps∕LÞ)f
DNDs 277.9 11.3 0.04 1.05 × 10−10 6.35 × 1013 44.8 × 10−13
SWNT (970 nm) 166.9 5.5 0.04 3.85 × 10−8 23.15 × 1015 7.21 × 10−15
AuNRs (760 nm) 268.3 3.6 1.11 7.09 × 10−9 4.27 × 1015 62.8 × 10−15
AuNRs (840 nm) 281.0 1.7 1.05 6.71 × 10−9 4.04 × 1015 69.6 × 10−15
aLaser fluence: 18 mJ∕cm2.
bMass concentration.
cCalculated by Cm · NA∕Ar.
dPA signal comparison on an atom basis.
eCalculated by Cm∕Mparticle, where MDND ∼ 0.63 fg and MAuNR ∼ 0.26 fg.
fPA signal comparison on a weight basis.
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4 Conclusion
In summary, DNDs can be synthesized with sub-100 nm nano-
scopic dimensions and with high optical absorption in the
NIR wavelengths ideal for optical contrast imaging. Our
ex vivo and in vivo results indicate that DNDs are superior to
AuNRs and SWNTs for PA imaging based on improved optical
absorption and known low toxicity.39 Compared with AuNRs
and SWNTs, DNDs have better PA amplitude on a mole and
weight basis. We envision that PA imaging with surface func-
tionalized DNDs could provide a powerful guidance tool for
drug delivery and imaging in deep tissues.
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